Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
InnSight Technologies is a Swiss-based medical device company developing a high-precision robotic platform for ophthalmic surgery. A spin-off from the University of Bern and the Inselspital, the company addresses the technical challenges of delivering advanced therapeutics to the subretinal space. Their core technology utilizes robotic assistance to eliminate hand tremors and provide stable, micron-level precision during delicate eye procedures. This platform is specifically designed to facilitate the delivery of gene and cell therapies for treating conditions such as age-related macular degeneration and inherited retinal dystrophies. By enhancing surgical accuracy, InnSight Technologies aims to improve patient outcomes and enable the next generation of regenerative ophthalmic treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on InnSight Technologies.